EQS-News: APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential Seite 1
12.04.2023 - EQS-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential 12.04.2023 / 07:30 ... Seite 1
Source: wallstreet-online.de